Legal Representation
Attorney
Ben Natter
USPTO Deadlines
Next Deadline
1405 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20231121)
Due Date
November 21, 2029
Grace Period Ends
May 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 17, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 17, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 17, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 17, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 17, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Nov 21, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 21, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 20, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 19, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Oct 13, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Oct 7, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 6, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Sep 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 27, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Sep 7, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 7, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 7, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 27, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 7, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 7, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 18, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 7, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 10, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 10, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 21, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 7, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 7, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 7, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 7, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 7, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 9, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 9, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 9, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 26, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 20, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 20, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 20, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 21, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of new products, pharmaceutical preparations, and medical devices; scientific, medical, and pharmaceutical research and development; drug discovery services; providing medical and scientific research information in the field of medicine, medical devices, and pharmaceuticals; scientific investigations for medical purposes; Conducting research and clinical trials for others in the field of medicine, medical devices, and pharmaceuticals
First Use Anywhere:
20210900
First Use in Commerce:
20210900
Additional Information
Translation
The English translation of "Mandos" in the mark is "Controls" or "Commands".
Pseudo Mark
MAN DOS HEALTH
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTH"